Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

11 projects found matching your search criteria :

  1. Targeting peripheral cannabinoid receptors CB2 as a novel therapy to treat osteoarthritis

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Starowicz-Bubak

    INSTYTUT FARMAKOLOGII PAN

  2. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Monika Kluzek

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  3. Efficiency biomarkers in photodynamic therapy against lung cancer

    Call: PRELUDIUM 2 , Panel: NZ4

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  4. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marika Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  5. Identification and use of natural human-tropic AAVs as vectors for gene therapy applications targeting human liver.

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: prof. Leszek Lisowski

    Wojskowy Instytut Medyczny

  6. Targeting deregulated expression of anti-apoptotic proteins belonging to the Bcl-2 family in macrophages as a potential ...

    Call: SONATA 16 , Panel: NZ5

    Principal investigator: dr Maja Sochalska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  7. Novel therapy for pulmonary hypertension with dual mechanism of action: Myo-inositol trispyrophosphate targeting both pu...

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Michał Mączewski

    Centrum Medyczne Kształcenia Podyplomowego

  8. Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

    Call: OPUS 12 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  9. Identification and targeting molecular drug resistance mechanisms in adult B-cell acute lymphoblastic leukemia

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

  10. Targeting Nrf2-ARE pathway for chemoprevention and /or therapy of the liver and the pancreas cancers by naturally occurr...

    Call: OPUS 11 , Panel: NZ5

    Principal investigator: dr hab. Violetta Krajka-Kuźniak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  11. Functionalized mesoporous silica nanoflakes - biocharacterization and physicochemical properties

    Call: PRELUDIUM 11 , Panel: ST8

    Principal investigator: Martyna Trukawka

    Zachodniopomorski Uniwersytet Technologiczny w Szczecinie, Wydział Technologii i Inżynierii Chemicznej